JPRN-UMIN000012556Completed未知
Effect of omega-3 fatty acid on endothelial dysfunction induced by postprandial hypelipidemia - Effect of omega-3 fatty acid on endothelial dysfunction induced by postprandial hypelipidemia
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 sites10 target enrollmentStarted: December 12, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 85years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Subjects receiving hypoglycemic agents and lipid lowering agents 2. Subjects who is allergic to omega-3 fatty acid 3.Patients who are determined by the investigators to be unsuitable
Investigators
Similar Trials
Completed
Not Applicable
Effect of Omega-3 supplementation on endothelial function & quality of life in hemodialysis patientsEnd Stage Renal Disease.End Stage Renal DiseaseIRCT201309242417N13Vice Chancellor for Research, Isfahan University of Medical Sciences60
Recruiting
Phase 2
The effect of omega-3 supplementation on endothelial function, vascular structure and metabolic parameters in adolescents with type 1 diabetesType 1 diabetes mellitusIRCT20210419051010N1Iran University of Medical Sciences30
Active, not recruiting
Not Applicable
Effects of Omega-3-Fatty Acids on Arterial Endothelial Function and Intima Media Thickness in Children with Insulin-Dependent Diabetes MellitusEUCTR2006-004427-11-SEniv of Lund, Dept of Pediatrics40
Completed
Not Applicable
Fish Oils in LupusSystemic Lupus Erythematosus (SLE)Musculoskeletal DiseasesErythematosusISRCTN66445141Queen's University of Belfast (UK)60
Completed
Phase 2
The effect of omega 3 polyunsaturated fatty acid supplementation on inflammatory markers and insulin resistanse factors in patients with Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseCondition 1: type 2 diabetes. Condition 2: Nonalcoholic fatty liver disease (NAFLD).Non-insulin-dependent diabetes mellitusFatty (change of) liver, not elsewhere classified (NAFLD)IRCT2017103030489N2Yazd Shahid Sadoughi University of Medical Sciences48